openPR Logo
Press release

Opioid Withdrawal Syndrome Market Growth: Emerging Technologies and Strategic Insights 2025

10-07-2025 09:50 AM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Opioid Withdrawal Syndrome Market - DataM Intelligence

Opioid Withdrawal Syndrome Market - DataM Intelligence

Opioid Withdrawal Syndrome Market is estimated to grow at a CAGR of 5% during the forecast period 2024-2031.

DataM Intelligence unveils its latest report on the "Opioid Withdrawal Syndrome Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming to stay ahead in the competitive Market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/opioid-withdrawal-syndrome-market?sg

List of Top Key Player: USWM, LLC, Teva Pharmaceuticals USA, Inc., Braeburn Inc, Rosemont Pharmaceuticals Ltd, Mallinckrodt, Pfizer Inc, Alkermes, Inc, Vista Pharm LLC, Steris Healthcare Pvt Ltd, Accord Healthcare Inc.

Industry Developments:

✅ Indivior Settlement Over Opvee
On September 30, 2025, New York Attorney General Letitia James announced a settlement with Indivior, requiring the company to cease promoting its opioid overdose reversal drug, Opvee, and recall unauthorized doses.

✅ ElectroCore and Spark Biomedical Agreement
On February 27, 2025, electroCore, Inc. announced an agreement with Spark Biomedical Inc. to distribute Sparrow Ascent, a device aimed at opioid withdrawal management.

✅ March 18, 2025: Researchers at Virginia Commonwealth University have reformulated an opioid use disorder medication to extend its therapeutic effect, potentially offering a longer-lasting treatment for opioid addiction.

✅ On September 2, 2025, Purdue Pharma announced the expansion of low-cost opioid use disorder treatments to correctional facilities, aiming to improve access for incarcerated individuals.

Forecast Projection:

The Global Opioid Withdrawal Syndrome Market is poised for significant growth between 2025 and 2032. In 2024, the market maintained a steady upward trajectory, and with strategic initiatives by leading players accelerating adoption, the market is expected to soar throughout the forecast period. Companies leveraging these trends are well-positioned to capture emerging opportunities and maximize revenue potential.

Market Intelligence Research Process:

The Opioid Withdrawal Syndrome Market research report by DataM Intelligence combines primary and secondary data to deliver deep, actionable insights. It examines the full spectrum of factors shaping the industry, from government regulations and market conditions to competitive dynamics, historical trends, technological breakthroughs, upcoming innovations, and potential challenges. This comprehensive analysis not only highlights growth prospects but also identifies barriers, equipping businesses to navigate market volatility and capitalize on emerging opportunities.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=opioid-withdrawal-syndrome-market?sg

Key Segmentation:

By Drug Type (Lucemyra, Methadone, Buprenorphine, Naltrexone, Others)

By Route of Administration (Oral, Intravenous)

By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa)

Global Growth Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1 - Market Overview: Kickstarts the report with a comprehensive snapshot of the Opioid Withdrawal Syndrome Market, summarizing key segments by region, product type, and application. Highlights include market size, segment growth potential, and short- & long-term industry outlook.

Chapter 2 - Emerging Trends: Uncovers the game-changing trends and high-impact innovations shaping the future of the industry.

Chapter 3 - Competitive Landscape: Offers a deep dive into market competition, detailing revenue shares, strategic initiatives, and recent mergers & acquisitions.

Chapter 4 - Top Player Profiles: Features detailed company profiles, covering revenue, profit margins, product lines, and major milestones for leading market players.

Chapters 5 & 6 - Regional & Country Analysis: Breaks down revenue performance across global regions, providing insights on market sizes, opportunities, and growth prospects worldwide.

Chapter 7 - Segmentation Analysis: Explores market segmentation by type, revealing high-potential categories and guiding businesses towards lucrative areas.

Chapter 8 - Application Insights: Examines downstream markets and identifies promising sectors for expansion, showing how different applications are driving growth.

Chapter 9 - Supply Chain Mapping: Maps the entire industry supply chain, highlighting upstream and downstream activities for a holistic market perspective.

Chapter 10 - Key Takeaways: Concludes with critical insights and actionable strategies, equipping stakeholders to make informed decisions and stay ahead in the market.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/opioid-withdrawal-syndrome-market?sg

FAQ's

Q1: How fast is the Opioid Withdrawal Syndrome Market expected to grow in the coming years?

A: The market is forecast to expand at a robust CAGR of 5% between 2024-2031, signaling strong global growth and investment potential.

Q2: Which regions are dominating the Opioid Withdrawal Syndrome Market and which are fastest-growing?

A: North America is expected to hold the largest market share.

Request 2 Days Free Trials with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sg

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Opioid Withdrawal Syndrome Market Growth: Emerging Technologies and Strategic Insights 2025 here

News-ID: 4211171 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Chlorella Ingredients Market 2025 | Industry Developments, Future Growth, Share & Industry Insights | Parry Nutraceuticals, Seagrass Tech Private Limited, Sun Chlorella
Chlorella Ingredients Market 2025 | Industry Developments, Future Growth, Share …
Chlorella Ingredients Market Size reached US$ 174.05 million in 2024 and is expected to reach US$ 318.12 million by 2032, growing with a CAGR of 7.83% during the forecast period 2025-2032. DataM Intelligence unveils its latest report on the "Chlorella Ingredients Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging
The United States Ammonia Revolution: From Fertilizer to Zero-Carbon Fuel | Top Most Keyplayers - Yara International ASA, CF Industries Holdings, Inc., Potash Corp, Orica Limited
The United States Ammonia Revolution: From Fertilizer to Zero-Carbon Fuel | Top …
Market Size and Forecast: The Global Ammonia Market is expected to reach growth at a Significant CAGR during the forecast period (2025-2032). The Ammonia Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods,
Float Glass Market Growth: Emerging Technologies and Strategic Insights 2025 | AGC Inc, Saint-Gobain S.A, Asahi Glass Co Ltd, Nippon Sheet Glass
Float Glass Market Growth: Emerging Technologies and Strategic Insights 2025 | A …
Float Glass Market reached US$ 43.8 billion in 2023 and is expected to reach US$ 62.3 billion by 2031, growing with a CAGR of 4.5% during the forecast period 2024-2031. DataM Intelligence unveils its latest report on the "Float Glass Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities
Pouchitis Market Growth: Emerging Technologies and Strategic Insights 2025 | Ravoos Laboratories Ltd, Wellona Pharma, Aden Healthcare, Manus Aktteva Biopharma LLP, Anant Pharmaceuticals
Pouchitis Market Growth: Emerging Technologies and Strategic Insights 2025 | Rav …
Global Pouchitis Market is estimated to grow at a CAGR of 10% during the forecast period 2024-2031. DataM Intelligence unveils its latest report on the "Pouchitis Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with

All 5 Releases


More Releases for Opioid

Rising Opioid Use For Pain Management Fuels Growth In Opioid-Induced Constipatio …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Opioid-Induced Constipation Treatment Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for treatment of opioid-induced constipation has seen a substantial growth recently. It is expected to escalate from a solid $1.78 billion in 2024 to an impressive $1.9 billion in 2025, exhibiting
Growing Number Of Opioid Addiction Cases: Strategic Insights Driving Opioid Use …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Opioid Use Disorder (OUD) Market Size By 2025? The market size for opioid use disorder (OUD) has experienced a quick expansion in the past few years. The growth is projected to rise from $3.96 billion in 2024 to $4.39 billion in 2025, boasting a compound
Key Influencer in the Opioid-Induced Constipation Treatment Market 2025: Rising …
What combination of drivers is leading to accelerated growth in the opioid-induced constipation treatment market? The rise in opioid administration for cancer and non-cancer pain is expected to drive the growth of the opioid-induced constipation (OIC) treatment market. Opioids are commonly used for managing moderate to severe pain, but they can cause constipation. OIC treatments are vital for improving the quality of life for patients on opioids, allowing them to maintain
Top Factor Driving Opioid Use Disorder (OUD) Market Growth in 2025: Growing Numb …
How Are the key drivers contributing to the expansion of the opioid use disorder (oud) market? The rise in instances of opioid dependency is set to fuel the expansion of the opioid use disorder (OUD) market. Opioid dependency defines a health concern marked by habitual and uncontrolled opioid consumption which negatively impacts health. These opioids can generate feelings of bliss and relief from pain, but continued usage often results in tolerance
What's Driving the Opioid-Induced Constipation Treatment Market 2025-2034: Risin …
What Are the Projections for the Size and Growth Rate of the Opioid-Induced Constipation Treatment Market? The market size for treatments of constipation caused by opioids has seen robust growth lately. The forecasted growth indicates an increase from $1.78 billion in 2024 to $1.9 billion in 2025, representing a compound annual growth rate (CAGR) of 7.0%. This past growth is associated with a growing elderly population, individualized treatments for OIC, the
MEDICAL MARIJUANA AND THE OPIOID CRISIS
Marijuana from the Cannabis plant is classified as a psychoactive drug used for medical or recreational purposes. Although it has been used for decades, in the U.S., it is still illegal under federal law to use and possess marijuana. Get PDF Sample Brochure of this report at: https://decisionmarketreports.com/request-sample/1247622 Nevertheless, at the state level, policies regarding the medical and recreational use of Cannabis vary greatly, and in many states conflict significantly with federal